TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Three factors push the medical device plate group to be optimistic about 3 leading stocks
 
Author:中国铭铉 企划部  Release Time:2017-9-7 11:03:13  Number Browse:860
 
Medical network - on September 6th September 4, the state food and drug supervision and administration bureau held a press conference, released the new revision of the medical device classification catalogue (hereinafter referred to as the new "catalog"), the new "catalog" will come into effect on August 1, 2018. According to introducing, the new the catalog of classification framework to optimize the overall elaboration product category, expand coverage and adjusting the catalog management category three aspects, after implementation will promote medical device classification to implement dynamic management in our country.

Return to the secondary market, stocks do well, yesterday Wan Dong medical (4.42%) and Thailand (3.08%), kelly states (2.59%), diving medical instrument (2.16%), and other stocks up more than 2% yesterday, in addition, the market, chutian science and technology, ShangRong medical, xinhua medical, derrick, David medical, shandong medicine. Yesterday also outperform the market with good performance.

In this regard, the analysts said that, in combination, the news side promotes, the performance growth is healthy, the whole early period of the overall overfall becomes the medical device plate has achieved good performance in the recent three push.

Specific view, according to semi annual report disclosure of listed companies, the middle of this year two city medical equipment related to overall performance of listed companies to maintain rapid growth, there're a total of 16 companies 22 listed companies belonging to the parent company net profit year-on-year growth, including bond instrument to the current performance year-on-year growth of 116.35%, in addition, three Noel biological, pharmaceutical, shandong people medicine bo, derrick medical, kelly's 11 companies such as current performance year-on-year growth has exceeded twenty percent.

Correspond to surface integral to the good performance, since this year the market performance of listed companies related to common insipid, some individual stocks years shares also significant adjustments, including shares thereof, nine Ann medical, business, xinhua medical, dimensional force medical treatment, medical treatment, David ShangRong medical, Canaan technology, Wright, etc nine years stocks had fallen more than 20% in all.

To this, some analysts said the style in the market gradually to value investment background, with the whole cycle stocks has achieved significant rise, recent market funds also are actively looking for new value plays, and benefit from the rapid development of in vitro diagnostic field, maintain good degrees at a higher level of medical apparatus and instruments related listed companies, after the early stage of the whole big adjustment, the investment opportunity is expected by the market further digging, worth close tracking.

In fact, for the plate in anticipation of a good trend recently more and more the brokerage said bullish on stocks of medical equipment investment opportunities, the securities daily according to market research center flush data statistics found that in nearly 30 days 14 stocks have been institutions to "buy" or "overweight" rating on, accounted for 64%. Among them, the market (23), diving medical (21), dean diagnosis (16), and other three leading shares have been more than 10 institutions of collective value, moreover, has received three or more organizations to give good rating of individual stocks include bond instruments, and three biological, shandong medicine bo, chutian science and technology, Wan Dong medical, Wright, beautiful health biological treasure.
 
Previous article:Pharmacies conduct non - drug sales market analysis
Next article:API speed up! Vitamin companies are mixed
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粤公网安备 44011202000029号